EEF2K and neoplasm: (2) Many current ATP non-competitive eEF2K inhibitors have potent inhibitory effects in vitro, but their anti-tumor effects in vivo have not been studied, are not pronounced, or may be absent for any number of reasons that arise when advancing candidates from protein inhibition assays to whole cells in vitro and onward to animals.